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The syndrome of benign familial infantile convulsions (BFIC) is an autosomal dominant epileptic disorder that is
characterized by convulsions, with onset at age 3–12 mo and a favorable outcome. BFIC had been linked to
chromosome 19q, whereas the infantile convulsions and choreoathetosis (ICCA) syndrome, in which BFIC is
associated with paroxysmal dyskinesias, had been linked to chromosome 16p12-q12. BFIC appears to be frequently
associated with paroxysmal dyskinesias, because many additional families from diverse ethnic backgrounds have
similar syndromes that have been linked to the chromosome 16 ICCA region. Moreover, one large pedigree with
paroxysmal kinesigenic dyskinesias only, has also been linked to the same genomic area. This raised the possibility
that families with pure BFIC may be linked to chromosome 16 as well. We identified and studied seven families
with BFIC inherited as an autosomal dominant trait. Genotyping was performed with markers at chromosome 19q
and 16p12-q12. Although chromosome 19q could be excluded, evidence for linkage in the ICCA region was found,
with a maximum two-point LOD score of 3.32 for markers D16S3131 and SPN. This result proves that human
chromosome 16p12-q12 is a major genetic locus underlying both BFIC and paroxysmal dyskinesias. The unusual
phenotype displayed by one homozygous patient suggests that variability of the ICCA syndrome could be sustained
by genetic modifiers.
A large proportion of cases of idiopathic epilepsy are of
genetic origin. Mutations in ligand or voltage-gated ion-
channel genes have been identified in various epileptic
syndromes that are inherited as Mendelian traits (Stein-
lein et al. 1995; Steinlein et al. 1997; Biervert et al. 1998;
Charlier et al. 1998; Singh et al. 1998; Wallace et al.
1998; De Fusco et al. 2000; Escayg et al. 2000). Many
other epilepsy genes have been mapped by linkage anal-
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yses (Szepetowski and Monaco 1998; Leppert and Singh
1999; Steinlein 1999; Szepetowski 2000) but are not yet
known. Identification of these genes is important not
only with respect to the corresponding syndromes but
for its possible use in studying the more-frequent forms
of epilepsy that are inherited as complex traits. Benign
familial infantile convulsions (BFIC [MIM 601764]) is
one of the numerous epileptic syndromes whose under-
lying genes remain unknown. It is characterized by non-
febrile convulsions that begin at age 3–12 mo and have
a good response to anticonvulsants and a favorable out-
come (Vigevano et al. 1992; Lee et al. 1993; Echenne et
al. 1994; Caraballo et al. 1997). It is inherited as an
autosomal dominant trait, and linkage to chromosome
19q had been found in five Italian families (Guipponi et
al. 1997). Since then, several studies have shown evi-
Table 1
Clinical Data on Subjects with BFIC
COUNTRY PEDIGREE PATIENT SEX
AGE AT
ONSET
(mo)
SEIZURE
EEG
ANTIEPILEPTIC
DRUGSb
NEUROLOGICAL
EXAMINATIONc CT, MRI
LAST SEIZURE
(mo)
YEAR OF
BIRTHTypea Distribution Frequency
Argentina i I.2 F 6 ND Awake ND N None N N 6 1966
Argentina i II.1 M 6 CP Awake Isolated N PB N N 7 1990
Argentina i II.2 F 5 CPSG Awake Isolated N PB N N 6 1992
Argentina O I.1 M 3–6 GTC Awake Clusters N PB N ND !12 1962
Argentina O II.1 F 2 PMSG Awake Clusters N PB N N 10 1989
Argentina O II.2 F 3 GTC Awake Clusters N PB DS N 14 1991
Argentina P I.4 M 8 PMSG Awake ND N PB N N 12 1969
Argentina P II.2 M 6 PMSG Awake Clusters N CBZ N N 18 1997
Argentina K II.2 M 10 ND Awake ND ND PB N N 14 1959
Argentina K II.5 M 6 GTC Awake Clusters ND None N ND 6 1964
Argentina K III.2 M 4 CPSG Awake ND N PB, CBZ N N 11 1991
Argentina K III.3 F 3 CPSG Awake Clusters N PB, CBZ N N BECTSd 1995
Argentina K III.4 F 5 GTC Awake Clusters N None N N 5 1996
France F I.1 M !12 ND Awake ND ND None N ND !12 1944
France F II.2 F 3–6 ND Awake ND ND PB N ND 6 1967
France F III.2 F 4 ND Awake and asleep Clusters N CBZ N ND 4 1992
France F III.4 M 3 PMSG Awake and asleep Clusters N None N ND 3 1997
France C1 II.2 F !6 PMSG Awake ND ND None N ND !12 1953
France C1 II.5 F !12 PMSG Awake ND ND None N ND !12 1959
France C1 III.2 F 6 PMSG Awake Isolated ND None N ND 6 1975
France C1 III.4 F 6 PMSG Awake Isolated ND None N ND !12 1986
France C1 IV.1 M 3 PMSG Awake Isolated N DZP, CBZ, HYD, VGBe DYSK N 18 1996
France V I.1 M 4 GTC Awake Clusters N PHE N N 11 1994
France V II.2 M !12 GTC Awake Clusters ND PB N ND !12 1956
NOTE.—N p normal; ND p not determined.
a CP p complex partial; CPSG p CP secondary generalized; GTC p generalized tonic-clonic; PMSG p partial motor secondary generalized.
b CBZ p carbamazepine; DZP p diazepam; HYD p hydantoin; PB p phenobarbital; PHE p phenytoin; VGB p vigabatrin.
c DS p Down syndrome; DYSK p dyskinesia (from age 2 years).
d BECTS p benign epilepsy with centrotemporal spikes (from age 3 years).
e Treatments were not completely effective.
Figure 1 Pedigree and haplotype analysis of the families with autosomal dominant infantile convulsions. Blackened symbols indicate individuals with BFIC. Gray symbols indicate individuals with
an unknown phenotype. Microsatellite markers are listed in box at top left. The haplotype segregating with the disease in the families is boxed.
Reports 791
Table 2
Two-Point LOD Scores for Markers on Chromosomes 19q and
16p12-q12
CHROMOSOME
AND MARKER
LOD SCORE AT v p
.0 .01 .05 .1 .2 .3 .4
16 :
D16S401 .76 1.48 1.90 1.85 1.44 .94 .45
D16S3133 2.84 2.78 2.53 2.20 1.56 .96 .44
D16S3131 3.32 3.25 2.95 2.58 1.83 1.12 .50
D16S3093 3.23 3.15 2.86 2.49 1.76 1.07 .48
D16S313 2.83 2.76 2.47 2.11 1.41 .79 .31
SPN 3.32 3.25 2.95 2.58 1.83 1.12 .50
D16S517 1.53 1.49 1.30 1.07 .66 .33 .11
D16S415 2.44 .35 .18 .29 .23 .12 .04
19:
D19S250  4.79 2.19 1.23 .49 .22 .09
D19S114  2.33 1.06 .62 .29 .16 .07
D19S414  3.78 1.83 1.10 .51 .25 .09
D19S425  3.38 1.49 .83 .35 .17 .07
D19S412  4.85 2.23 1.25 .47 .18 .06
D19S606  4.53 1.95 1.02 .34 .11 .03
D19S904 3.50 .96 .36 .17 .08 .07 .05
D19S926  3.32 1.41 .73 .25 .09 .04
D19S210  3.46 1.50 .77 .20 .01 .06
dence that the mechanisms underlying paroxysmal
movement disorders (dyskinesia) and BFIC are similar
(Berkovic 1999). A new autosomal dominant syndrome
had been described in four French families in which both
BFIC and paroxysmal choreoathetotic dyskinesia oc-
curred. Linkage of this syndrome (ICCA [MIM602066])
at chromosome 19q was excluded, and evidence for link-
age was found at chromosome 16p12-q12, between
markers D16S401 and D16S517 (Szepetowski et al.
1997). Infantile convulsions associated with various
types of paroxysmal dyskinesias have been linked to the
chromosome 16 ICCA region in additional families (Lee
et al. 1998; Tomita et al. 1999; Swoboda et al. 2000).
Moreover, one large black family with paroxysmal
kinesigenic dyskinesia (PKC [MIM 128200]) but with-
out infantile convulsions had been linked to the ICCA
region (Bennett et al. 2000). Because patients in the fam-
ilies with ICCA could display either BFIC or paroxysmal
dyskinesias or both, it is likely that disease in families
with pure BFIC is linked to the ICCA region as well.
In the present study, seven families in Argentina and
France with pure BFIC inherited as an autosomal dom-
inant trait were identified and studied. Individuals were
considered to be affected with BFIC if they had nonfe-
brile convulsions (simple partial seizures, complex par-
tial seizures, or apparently generalized seizures), with
onset at age 2–12 mo without recognized etiology, with
a favorable outcome, and with a familial history of sim-
ilar seizures (table 1). DNA samples were tested with
highly polymorphic markers situated at chromosome
16p12-q12 and at chromosome 19q. Fluorescent PCR
products were analyzed on 373A sequencers (PEApplied
Biosystems), using the GENESCAN and GENOTYPER
softwares. Linkage analysis was performed assuming au-
tosomal dominant mode of inheritance and using an
affected-members-only method, and with frequency of
the disease allele at .0001, by use of MLINK in the
LINKAGE computer package (Lathrop and Lalouel
1984). Markers spaced regularly across 19q (Dib et al.
1996; Ge´ne´thon Database) gave significant negative
LOD scores (table 2), thereby excluding this genomic
area. This result also was consistent with previous ex-
clusion of chromosome 19q in several families with BFIC
(Gennaro et al. 1999; Giordano et al. 1999; Baralle et
al. 2000) and confirmed the genetic heterogeneity of
BFIC. By contrast, linkage to chromosome 16p12-q12
was demonstrated with several informativemarkers, and
a maximum two-point LOD score of 3.32 ( ) forvp 0
D16S3131 and SPN (table 2).
To our knowledge, this is the first time that pure BFIC
syndrome has been linked to chromosome 16. Together
with data on ICCA and PKC syndromes reported else-
where, the present study proves that human chromo-
some 16p12-q12 is a major genetic locus underlying
both BFIC and paroxysmal dyskinesias. Alterations at
this locus could lead to the various clinical components
characterizing the ICCA syndrome. Analysis of meiotic
recombination events did not help to narrow the critical
ICCA region. Although families had been studied in Ar-
gentina and France and although a large proportion of
the Argentinian population is of European descent, no
evidence could be found for a common origin of the
families. Moreover, no common haplotype was signifi-
cantly shared across the families. Allele 3 for marker
D16S517 was present in all affected individuals (fig. 1)
but appeared to be very frequent in the white population
(71%, according to the Genome Database). No ion-
channel gene has been mapped to the critical area. We
expect that progress in the sequencing of the human
genome will help to identify new candidate genes that
can be tested for mutation in the numerous families that
are linked to the ICCA region. However, recent data
suggested that mutations in more than one gene at chro-
mosome 16p12-q12 may give rise to similar and over-
lapping syndromes, making the search for the disease
gene(s) more complicated. Paroxysmal dyskinesia of the
kinesigenic type (PKC [MIM 128200]) has been linked
to chromosome 16q13-q22 in a single Indian family
(Valente et al. 2000). The critical region showed no over-
lap with any of the critical regions defined in previous
studies (fig. 2). Moreover, a recessive syndrome in which
rolandic epilepsy is associated with paroxysmal exer-
tional dyskinesia had been linked to chromosome 16p12
by homozygosity mapping (Guerrini et al. 1999). The
condition is also known as the “RE-PED-WC syn-
drome.” Once again, the critical region was not consis-
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Figure 2 Schematic representation of the genetic map of human
chromosome 16p12-q12. Markers have been located according to Dib
et al. (1996) and to data from the present study, as well as according
to maps published elsewhere (Szepetowski et al. 1997; Tomita et al.
1999; Valente et al. 2000). Markers shown in italics and marked by
arrows are those whose relative locations are controversial. Critical
regions are indicated as follows: 1p BFIC (the present study); 2p ICCA
syndrome (Szepetowski et al. 1997); 3 p PKC (Valente et al. 2000); 4
p RE-PED-WC syndrome (Guerrini et al. 1999); 5 p PKC and BFIC
(Tomita et al. 1999); 6 p PKC and BFIC (Swoboda et al. 2000); and
7 p PKC (Bennett et al. 2000).
tent with a single-gene hypothesis (fig. 2). Duplication
events could have sustained the existence of two ho-
mologous genes lying in close vicinity at 16p12-q12
(Loftus et al. 1999). Other explanations for this apparent
complexity cannot be ruled out. Genotyping errors or
inconsistencies in the genetic maps (see fig. 2) could have
led to misinterpretation in the definition of the overlaps
between the critical regions.
Significant LOD scores were obtained, assuming
65% penetrance (data not shown). The highest LOD
scores were obtained when only affected members
were included in statistical analysis (table 2). This re-
sulted because some families included unaffected in-
dividuals carrying the disease haplotypes (fig. 1). Pen-
etrance rates were even lower than in families with
ICCA syndrome; this is not surprising, considering
that the families with BFIC linked to chromosome 16
display an unusual ICCA syndrome, with no parox-
ysmal dyskinesia in heterozygous patients. Data re-
ported elsewhere (Szepetowski et al. 1997) clearly
showed that the ICCA syndrome could be variably
expressed within the same family. It is also noteworthy
that infantile convulsions in the families with BFIC
cannot be distinguished from those in families with
ICCA. Before the analysis, systematic searchers for
paroxysmal dyskinesia were conducted in the families
with BFIC, making it unlikely that the dyskinesia was
present but not detected. We cannot exclude the pos-
sibility that the youngest patients (!20 years old) may
develop dyskinesia later in life. However, this did not
occur for any of the individuals 20 years old in the
seven families, including those family members who
could not be studied for the present report.
Variable presentation of the ICCA syndrome could be
the result of allelic variations. However, the disease could
be variably expressed in patients from the same family.
It is also well known that paroxysmal disorders can be
triggered by a large variety of external stimuli, which
could explain the incomplete penetrance and the variable
clinical manifestations. Another likely explanation is
that modifying genes may be present. This would be
consistent with the unexpected findings in one member
of pedigree C1 (patient IV.1). This patient belonged to
a consanguineous family and appeared to carry two cop-
ies of the disease haplotype. The clinical status of his
father (II.1) and grandmother (I.2) could not be ascer-
tained, and no DNA was available. However, there is
no doubt that I.2 and II.1 inherited the disease haplotype
that was transmitted to IV.1, because patient IV.1 was
homozygous for all markers at 16p12-q12. This is the
first time that a homozygous patient with BFIC has been
described. The infantile convulsions of patient IV.1 did
not respond well to anticonvulsants, in contrast to all
other affected members of his family and to classical
BFIC. Moreover, although the families had been selected
on the basis of clinical evidence of BFIC only, this patient
started having atypical paroxysmal choreic/dystonicdys-
kinesia at age 2 years; these attacks were detected while
the analysis was under way. The patient’s age at onset
is earlier than that of classical paroxysmal dyskinesias
(which usually begins at age 5–16 years). The type of
dyskinesia was difficult to assess. Dyskinetic movements
sometimes occurred a few seconds after starting exer-
tion, which suggests kinesigenic type. However, the pa-
tient did not respond to carbamazepine, a finding that
is consistent with an exertional type rather than with a
kinesigenic one. Moreover, abnormal movements could
occur later in life without any clear triggering factor.
These paradoxical clinical features have already been
a matter of debate (Guerrini et al. 2000) andmay suggest
the existence of overlapping forms of dyskinesia that also
may change with time. Homozygous mutation in the
putative ICCA genemay thus have led to the appearance,
in this unusual patient, of paroxysmal dyskinesia and to
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resistance to anticonvulsants, whereas heterozygousmu-
tation in this family would sustain only classical infantile
convulsions. This finding could provide interesting clues
to understanding the different phenotypes observed in
the ICCA syndrome. For example, the ICCA protein
could associate with itself as well as with other proteins
to form a multimeric functional protein. This has been
described for KCNQ2 (KCNQ2 [MIM 602235]) and
KCNQ3 (KCNQ3 [MIM 602232]) products in the case
of benign neonatal familial convulsions (Rogawski
2000). Modifying genes could act similarly in hetero-
zygous ICCA patients and make the clinical manifes-
tations of the ICCA syndrome highly variable.
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